Boston Scientific Earnings: Here’s Why Investors are Bidding Shares Higher

  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Boston Scientific Corporation (NYSE:BSX) delivered a profit and met Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. The company also announced it will trim up to 1,000 jobs in a restructuring effort this year. Shares are up 5.36%.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

Boston Scientific Corporation Earnings Cheat Sheet

Results: Net income decreased -43.93% to $60 million (4 cents per diluted share) in the quarter versus a net gain of $107 million in the year-earlier quarter.

Revenue: Decreased 1.46% to $1.82 billion from the year-earlier quarter.

Actual vs. Wall St. Expectations: Boston Scientific Corporation reported adjusted net income of 11 cents per share. By that measure, the company met the mean analyst estimate of $0.11. It beat the average revenue estimate of $1.76 billion.

Quoting Management: “We are pleased but not satisfied with our improved performance in the quarter,” said Mike Mahoney, President and CEO, Boston Scientific…

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business